AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionMASTER LARGE CAP SERIES LLC - Master Advantage Large Cap Core Portfolio
Latest Disclosed Ownership21,010 shares
Latest Disclosed Value $ 3,405,931
MASTER LARGE CAP SERIES LLC - Master Advantage Large Cap Core Portfolio reports 83.60% decrease in ownership of ABBV / AbbVie Inc.

On May 26, 2022 - MASTER LARGE CAP SERIES LLC - Master Advantage Large Cap Core Portfolio filed a NPORT-P form disclosing ownership of 21,010 shares of AbbVie Inc. (US:ABBV) valued at $3,405,931 USD as of March 31, 2022. The entity filed a previous NPORT-P on February 24, 2022 disclosing 128,077 shares of AbbVie Inc.. This represents a change in shares of -83.60% during the quarter. The current value of the position is $4,774,102 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2022-05-26 2022-03-31 NP AbbVie EC US00287Y1091 21,010 -107,067 -83.60 3,406 -80.36 0.0775
2022-02-24 2021-12-31 NP AbbVie EC US00287Y1091 128,077 128,077 17,342 0.3661
2021-11-24 2021-09-30 NP ABBVIE EC US00287Y1091 0 -105,961 -100.00 0 -100.00
2021-08-24 2021-06-30 NP ABBVIE EC US00287Y1091 105,961 -123,693 -53.86 11,935 -51.98 0.2712
2021-05-24 2021-03-31 NP ABBVIE EC US00287Y1091 229,654 -8,460 -3.55 24,853 -2.59 0.6073
2021-02-23 2020-12-31 NP ABBVIE EC US00287Y1091 238,114 -212,188 -47.12 25,514 -35.31 0.6320
2020-11-20 2020-09-30 NP ABBVIE EC US00287Y1091 450,302 -406 -0.09 39,442 -10.87 1.0705
2020-08-25 2020-06-30 NP ABBVIE EC US00287Y1091 450,708 27,587 6.52 44,251 37.26 1.2769
2020-05-26 2020-03-31 NP ABBVIE EC US00287Y1091 423,121 150,766 55.36 32,238 33.69 1.1301
2020-02-27 2019-12-31 NP ABBVIE EC 00287Y109 272,355 -33,568 -10.97 24,114 4.10 0.6515
2019-11-26 2019-09-30 NP ABBVIE EC US00287Y1091 305,923 305,923 23,164 0.6655
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.